NCT06264934 An Investigation Into Dielectric Assessment of Permittivity and Conductivity in Human Using a Novel Electrical Capacitance Tomography Scanner
| NCT ID | NCT06264934 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zedsen Limited |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-01-25 |
| Primary Completion | 2024-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 90 participants in total. It began in 2024-01-25 with a primary completion date of 2024-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to investigate the ability of a the Z-scanner to identify and differentiate cancer and benign lesions from healthy breast tissue based on permittivity. The main questions it aims to answer are: 1. Determine the permittivity values of the Z-scanner associated with healthy, benign, and malignant tissue in human breasts. 2. Determine the repeatability, reproducibility, inter-and intra-operator variability of the Z-scanner.
Eligibility Criteria
Inclusion Criteria: * Attending a symptomatic clinic or other appointment at a participating breast clinic site * Assigned female sex at time of birth * Aged 18 years or older at time of scan * Willing, able and mentally competent to read, understand, and provided informed consent in English Exclusion Criteria: * Participants who have undergone biopsy less than 14 days before the Z-scanner scan * Participants with implanted electronics * Participants with breast implants * Participants with nipple piercings (unless they are removed prior to the scan) * Participants who are lactating * Pregnant participants by verbal confirmation * Participants with pacemakers * Participants with open breast wound * Participants who had previous breast surgery (mastectomy, lumpectomy)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06264934 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06264934 currently recruiting?
Yes, NCT06264934 is actively recruiting participants. Contact the research team at jessica@zedsen.com for enrollment information.
Where is the NCT06264934 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT06264934 clinical trial?
NCT06264934 is sponsored by Zedsen Limited. The trial plans to enroll 90 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.